AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JUDGES SCIENTIFIC PLC

Share Issue/Capital Change Oct 21, 2015

7734_dirs_2015-10-21_f353fff7-4f6d-49f7-a240-9f9d9a764519.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9706C

Judges Scientific PLC

21 October 2015

Judges Scientific plc

("Judges" or the "Group")

New share option schemes, grant of options and Director/PDMR shareholding

Judges Scientific Plc, the parent company of a group specialising in the design, manufacture and sale of scientific instruments, announces that the Board has today approved two new share option plans, one approved and one unapproved to replace the two existing schemes that recently lapsed (collectively "the Option Schemes"). Under the Option Schemes the Board may grant options over ordinary shares of 5p in the Group ("Ordinary Shares") to senior management and employees as means to retain and incentivise staff. 60,216 options have today been granted, with an exercise price of 1402.5p, to certain senior management of the Group

In addition, options over 12,500 Ordinary Shares in total have been awarded under the unapproved share option plan to David Cicurel, Chief Executive Officer and David Barnbrook, Chief Operating Officer. The options have been awarded as follows:

Director Number of options Exercise price (p) Vesting date Expiry date
David Cicurel 7,500 1402.5 21 October 2018 21 October 2025
David Barnbrook 5,000 1402.5 21 October 2018 21 October 2025

The exercise price was set based on the closing mid-market price of the Ordinary Shares as derived from the LSE for Tuesday, 20 October 2015. The options vest subject to continued employment within the Group.

Following these transactions, David Cicurel retains 916,652 Ordinary Shares in the Group, representing 15.10% of Judge's issued share capital and total voting rights. In addition, David Cicurel holds 9,275 options over Ordinary Shares. David Barnbrook retains 21,953 Ordinary Shares in the Group, representing 0.36% of Judges's issued share capital and total voting rights. In addition, David Barnbrook holds 28,325 options over Ordinary Shares.

For further information please contact:

Judges Scientific Plc

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: 020 3829 6970

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Nadja Vetter 

Tel: 020 7930 0777 or 07941 340 836

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBGBDGXUDBGUB

Talk to a Data Expert

Have a question? We'll get back to you promptly.